Research facility · founded 1955
Friends Research Institute
Baltimore, United States · friendsresearch.org
- Citations, last 5 years
- 2 249
- Works, last 5 years
- 337
- h-index
- 125
- Scientists listed
- 0
- Grants since 2016
- 82
Grants received
2025–2027 · research · R21
Leveraging a time-limited opportunity to study the impact of an intervention for individuals bereaved by drug overdose
Karli Rae Hochstatter · Friends Research Institute · funded by National Institutes of Health
2025–2030 · research · R01
A Patient Navigation Trial for Housing and Health (PATHH): A randomized controlled trial
Karen Alexander · Friends Research Institute · funded by National Institutes of Health
2025–2030 · cooperative agreement · UM1
A patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail
Thomas Blue · Friends Research Institute · funded by National Institutes of Health
2024–2025 · research · R01
Addressing substance use among the social networks of suspected drug overdose decedents: rapidly translating epidemiology into prevention intervention science
Karli Rae Hochstatter · Friends Research Institute · funded by National Institutes of Health
2024–2027 · research · R34
Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform
Helen-Maria Lekas · Friends Research Institute · funded by National Institutes of Health
2024–2026 · research · R34
Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform
Helen-Maria Lekas · Friends Research Institute · funded by National Institutes of Health
2023–2025 · cooperative agreement · UG3
Continuing Care App for Justice-Involved Individuals with Substance Use Disorders
Steven Bernard Carswell · Friends Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Comparative- and cost-effectiveness research determining the optimal intervention for advancing transgender women living with HIV to full viral suppression
Sean M. Murphy · Friends Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting
Thomas Blue · Friends Research Institute · funded by National Institutes of Health
2023–2027 · research · R18
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids
Helen-Maria Lekas · Friends Research Institute · funded by Agency for Healthcare Research and Quality
2023–2025 · cooperative agreement · UG3
Continuing Care App for Justice-Involved Individuals with Substance Use Disorders
Steven Bernard Carswell · Friends Research Institute · funded by National Institutes of Health
2023–2027 · research · R18
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids
Helen-Maria Lekas · Friends Research Institute · funded by Agency for Healthcare Research and Quality
2023–2026 · cooperative agreement · UG1
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
Thomas Blue · Friends Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting
Thomas Blue · Friends Research Institute · funded by National Institutes of Health
2023–2025 · research · R61
Implementing a patient navigation intervention across a health system to address treatment entry inequities
Karen Alexander · Friends Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Comparative- and cost-effectiveness research determining the optimal intervention for advancing transgender women living with HIV to full viral suppression
Sean M. Murphy · Friends Research Institute · funded by National Institutes of Health
2023–2029 · research · R01
A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting
Thomas Blue · Friends Research Institute · funded by National Institutes of Health
2023–2025 · research · R01
Comparative- and cost-effectiveness research determining the optimal intervention for advancing individuals living with HIV to full viral suppression
Sean M. Murphy · Friends Research Institute · funded by National Institutes of Health
2023–2029 · research · R33
Implementing a patient navigation intervention across a health system to improve outcomes for patients with opioid use disorder
Karen Alexander · Friends Research Institute · funded by National Institutes of Health
2022–2026 · research · R34
Intervention to Reduce Internalized Stigma (IRIS) among People Living with HIV who use Substances
Jesse Bradford Fletcher · Friends Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder
Sean M. Murphy · Friends Research Institute · funded by National Institutes of Health
2022–2025 · research · R34
Intervention to Reduce Internalized Stigma (IRIS) among People Living with HIV who use Substances
Jesse Bradford Fletcher · Friends Research Institute · funded by National Institutes of Health
2022–2025 · research · R21
Development and Testing of an Identity Measure for Transgender and Gender Diverse Persons
Jesse Bradford Fletcher · Friends Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder
Sean M. Murphy · Friends Research Institute · funded by National Institutes of Health
2022–2024 · research · R21
Development and Testing of an Identity Measure for Transgender and Gender Diverse Persons
Jesse Bradford Fletcher · Friends Research Institute · funded by National Institutes of Health
2022–2025 · research · R01
Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology
Karen Alexander · Friends Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2022–2025 · research · R01
Identifying Suspected Drug Overdose Deaths in Near Real-Time Using Data Collected by Death Investigators
Karli Rae Hochstatter · Friends Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder
Sean M. Murphy · Friends Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2022–2025 · research · R34
Intervention to Reduce Internalized Stigma (IRIS) among People Living with HIV who use Substances
Jesse Bradford Fletcher · Friends Research Institute · funded by National Institutes of Health
2022–2028 · research · R01
Identifying Suspected Drug Overdose Deaths in Near Real-Time Using Data Collected by Death Investigators
Karli Rae Hochstatter · Friends Research Institute · funded by National Institutes of Health
2022–2025 · research · R01
Optimizing PrEP Implementation and Cost-effectiveness among Individuals with a Substance Use Disorder
Sean M. Murphy · Friends Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology
Karen Alexander · Friends Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Take-home expansion: Scope and impact study (THESIS)
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health
2020 · research · ANI LLC
Friends Research Institute Inc
Friends Research Institute · funded by Arnold Ventures
2019–2024 · cooperative agreement · UG1
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
Michael Scott Gordon · Friends Research Institute · funded by National Institutes of Health
2019–2025 · research · R01
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
Jan Gryczynski · Friends Research Institute · funded by National Institutes of Health